Inflammatix, Inc.
Biotechnology company · Burlingame, California, United States
Inflammatix, Inc. is a biotechnology company headquartered in Burlingame, California, United States. Its earliest recorded incorporation is in 2016. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $102 million sold in a notice filed in 2021.
Inflammatix at a glance
What does Inflammatix do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2021 to 2023). NIH funding came from the National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $102.4 million sold (2021).
A site under this name is registered with the FDA by Inflammatix (1 650-443-3030).
Frequently asked questions about Inflammatix
Where is Inflammatix headquartered?
Inflammatix, Inc. is headquartered in Burlingame, California, United States.
What does Inflammatix do?
Inflammatix, Inc. is a biotechnology company.
When was Inflammatix founded?
The earliest incorporation on record for Inflammatix, Inc. is in 2016, according to public company registers.
Similar companies
- Hinge Bio, Inc.Burlingame, California, United States
- Magnus Medical, Inc.Burlingame, California, United States
- Optofluidics, Inc.Burlingame, California, United States
- Afasci, Inc.Burlingame, California, United States
- Nextrast, IncBurlingame, California, United States
- Attralus, Inc.Burlingame, California, United States
- Biodesy LLCBurlingame, California, United States
- Color Health, Inc.Burlingame, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences